{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:34:47Z","timestamp":1759336487276},"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.euroneuro.2015.09.005","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T22:48:22Z","timestamp":1442616502000},"page":"2289-2299","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Testing the antidepressant properties of the peptide ARA290 in a human neuropsychological model of drug action"],"prefix":"10.1016","volume":"25","author":[{"given":"Hil\u00e2l","family":"Cerit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya M.","family":"Veer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke","family":"Niesters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine J.","family":"Harmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamilla W.","family":"Miskowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge A.R.B.","family":"Rombouts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem","family":"Van der Does","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.09.005_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00213-008-1410-6","article-title":"Early effects of mirtazapine on emotional processing","volume":"203","author":"Arnone","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.euroneuro.2010.09.007","article-title":"Emotional processing as a predictor of symptom change: an acute tryptophan depletion study in depressed patients","volume":"21","author":"Booij","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib4","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood\u2013brain barrier to protect against experimental brain injury","volume":"97","author":"Brines","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrn1687","article-title":"Emerging biological roles for erythropoietin in the nervous system","volume":"6","author":"Brines","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib6","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.0805594105","article-title":"Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin","volume":"105","author":"Brines","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2119\/molmed.2011.00414","article-title":"The receptor that tames the innate immune response","volume":"18","author":"Brines","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/0269881106074062","article-title":"A single dose of citalopram increases fear recognition in healthy subjects","volume":"21","author":"Browning","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2119\/molmed.2013.00122","article-title":"ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density","volume":"19","author":"Dahan","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.mp.4001907","article-title":"Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin","volume":"12","author":"Ehrenreich","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib11","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1093\/brain\/awm203","article-title":"Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis","volume":"130","author":"Ehrenreich","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib12","series-title":"Pictures of Facial Affect","author":"Ekman","year":"1976"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000232558","article-title":"Erythropoietin sustains cognitive function and brain volume after neonatal stroke","volume":"31","author":"Gonzalez","year":"2009","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1176\/appi.ajp.160.5.990","article-title":"Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity","volume":"160","author":"Harmer","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib16","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1176\/appi.ajp.161.7.1256","article-title":"Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake Inhibition","volume":"161","author":"Harmer","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1192\/bjp.bp.108.051193","article-title":"Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action","volume":"195","author":"Harmer","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1177\/0269881110367722","article-title":"Efficacy markers in depression","volume":"25","author":"Harmer","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib19","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2119\/molmed.2012.00332","article-title":"Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a\u00a0randomized, double-blind pilot study","volume":"18","author":"Heij","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","article-title":"A global optimisation method for robust affine registration of brain images","volume":"5","author":"Jenkinson","year":"2001","journal-title":"Med. Image Anal."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/nimg.2002.1132","article-title":"Improved optimization for the robust and accurate linear registration and motion correction of brain images","volume":"17","author":"Jenkinson","year":"2002","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib22","series-title":"International Affective Picture System (IAPS): Affective Ratings of Pictures and Instruction Manual","author":"Lang","year":"2005"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1080\/02699930903485076","article-title":"Presentation and validation of the radboud faces database","volume":"24","author":"Langner","year":"2010","journal-title":"Cogn.\u00a0Emot"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10401230209147454","article-title":"Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine","volume":"14","author":"Masand","year":"2002","journal-title":"Ann.\u00a0Clin. Psychiaty"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1162\/jocn.1997.9.5.605","article-title":"Face-specific processing in the human fusiform gyrus","volume":"9","author":"McCarthy","year":"1997","journal-title":"J. Cognitive Neurosci."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.biopsych.2007.01.011","article-title":"Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action","volume":"62","author":"Miskowiak","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib27","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1523\/JNEUROSCI.5013-06.2007","article-title":"Erythropoietin enhances hippocampal response during memory retrieval in humans","volume":"27","author":"Miskowiak","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-007-0907-8","article-title":"Erythropoietin has no effect on hippocampal response during memory retrieval 3 days post\u2010administration","volume":"195","author":"Miskowiak","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.npp.1301439","article-title":"Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration","volume":"33","author":"Miskowiak","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/npp.2013.335","article-title":"Recombinant human erythropoietin for treating treatment-resistant depression: a\u00a0double-blind, randomized, placebo-controlled phase 2 trial","volume":"39","author":"Miskowiak","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1017\/S1461145708009164","article-title":"Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers","volume":"12","author":"Murphy","year":"2009","journal-title":"Int. J. Neuropsychooharmacol."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1192\/bjp.bp.108.056093","article-title":"Effect of a single dose of citalopram on amygdala response to emotional faces","volume":"194","author":"Murphy","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib33","series-title":"National Adult Reading Test","author":"Nelson","year":"1982"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/21678707.2013.719289","article-title":"The erythropoietin analog ARA 290 for treatment of sarcoidosis-induced chronic neuropathic pain","volume":"1","author":"Niesters","year":"2013","journal-title":"Expert Opin.\u00a0Orphan Drugs"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1192\/bjp.bp.106.031393","article-title":"Short-term antidepressant treatment and facial processing: functional magnetic resonance imaging study","volume":"190","author":"Norbury","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00213-010-1983-8","article-title":"A single dose of mirtazapine modulates neural responses to emotional faces in healthy people","volume":"212","author":"Rawlings","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib38","series-title":"De Nederlandse Leestest voor Volwassenen. [The Dutch Adult Reading Test.]","author":"Schmand","year":"1992"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","article-title":"The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability","volume":"12","author":"Sheehan","year":"1997","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib40","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1523\/JNEUROSCI.21-24-09733.2001","article-title":"Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells","volume":"21","author":"Shingo","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004010000297","article-title":"Erythropoietin and erythropoietin receptor in human ischemic\/hypoxic brain","volume":"101","author":"Sir\u00e9n","year":"2001","journal-title":"Acta. Neuropathol."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hbm.10062","article-title":"Fast robust automated brain extraction","volume":"17","author":"Smith","year":"2002","journal-title":"Hum Brain Mapp."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S0033291796004382","article-title":"A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects","volume":"27","author":"Spinhoven","year":"1997","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib45","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V95.9.2983.009k27_2983_2989","article-title":"Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans","volume":"95","author":"Stohlawetz","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2009.01.028","article-title":"The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients","volume":"118","author":"Tranter","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement\u2010based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib49","series-title":"De MINI-Inter-nationaal Neuropsychiatrisch Interview","author":"Van Vliet","year":"2000"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib50","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: the PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J. Pers. Soc. Psychol."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib51","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1055\/s-0038-1665442","article-title":"Erythropoietin administration increases production and reactivity of platelets in dogs","volume":"78","author":"Wolf","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.euroneuro.2015.09.005_bib52","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1006\/nimg.2001.0931","article-title":"Temporal autocorrelation in univariate linear modeling of FMRI data","volume":"14","author":"Woolrich","year":"2001","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib53","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.neuroimage.2003.12.023","article-title":"Multilevel linear modelling for FMRI group analysis using Bayesian inference","volume":"21","author":"Woolrich","year":"2004","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2015.09.005_bib54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta. Psychiat. Scand."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15002928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15002928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T13:21:53Z","timestamp":1599571313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15002928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0924977X15002928"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.09.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing the antidepressant properties of the peptide ARA290 in a human neuropsychological model of drug action","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}